Open AccessFeasibility and Tolerability of Lenvatinib, Plus PD-1 Blockades for Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Exploratory Study
Author(s) -
Jian Meng,
Jiang-Kun Jia,
Jian Xu,
Hao Xue
Publication year - 2022
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s372125
Subject(s) - lenvatinib , medicine , tolerability , hepatocellular carcinoma , progressive disease , gastroenterology , adverse effect , retrospective cohort study , oncology , response evaluation criteria in solid tumors , sorafenib , disease